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Abstract
Role of ER exit sites in GRASP-mediated unconventional secretion pathway
He Piao
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Min Goo Lee)
Deletion of phenylalanine at position 508 of the transmembrane protein CFTR is the most 
common form of disease-causing CFTR mutation, results in protein misfolding and 
deficiency of expressing at the cell surface. It has been shown that ER-to-Golgi blockade or 
GRASP overexpression could activate ΔF508-CFTR to be rescued to the cell surface 
through a Golgi by-pass unconventional secretion pathway. However, it is entirely unknown 
how misfolded ΔF508-CFTR can exit the endoplasmic reticulum (ER) membrane. Here we 
show that Sec16A, the key regulator of ER exit sites (ERES) formation is involved in the 
initiation of unconventional secretion. We found that dysfunction of Sec16A abolished both 
conventional and unconventional secretion of CFTR but other COPII-related components 
did not. During the unconventional secretion, Sec16A associated with GRASP and 
synchronized its localization change with GRASP, indicating that Sec16A supported
GRASP to assemble with ΔF508-CFTR at the ERES nearby the cell periphery. Moreover, 
IRE1α-mediated UPR was identified as an upstream regulator for Sec16A responding to ER 
stress associated with unconventional secretion. These findings highlight the novel function 
of Sec16A working as key regulator for ER stress associated unconventional secretion.
Key Words: CFTR, ER exit sites, Sec16A, GRASP, unconventional secretion, IRE1α
- 2 -
Role of ER exit sites in GRASP-mediated unconventional secretion pathway
He Piao
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Min Goo Lee)
I. INTRODUCTION
Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane associated, 
N-linked glycoprotein with anion channel activity which is encoded by the gene associated 
with cystic fibrosis.1 The CFTR protein can exist as non-glycosylated, core-glycosylated 
and complex-glycosylated (fully mature) forms.2 CFTR is a cyclic AMP (cAMP)-activated 
chloride and bicarbonate channel and the fully glycosylated mature CFTR can express in the 
plasma membrane (PM) of secretory epithelia in the airways, intestine, pancreas and 
exocrine glands.3,4 Therefore, loss-of-function mutations in CFTR causes autosomal 
recessive diseases associated with cystic fibrosis (CF) and other human diseases including 
bronchiectasis and chronic pancreatitis.5,6 The most common cystic fibrosis (CF)-causing 
CFTR mutation is a three base pair deletion resulting in loss of phenylalanine residue at the
position 508 (ΔF508).7 ΔF508-CFTR is an incompletely glycosylated mutation which has 
defect in its folding resulting in its retention in the endoplasmic reticulum (ER) and being 
targeted to ER-associated degradation (ERAD) pathway.8 However, the core-glycosylated 
ΔF508-CFTR can also function as a chloride channel when its dysfunction was corrected 
and transported to the cell surface.9
What’s interesting is the core-glycosylated ΔF508-CFTR or wild-type CFTR can travel to 
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the cell surface through a Golgi reassembly stacking protein (GRASP)-dependent Golgi-
bypass manner,10 which is known as unconventional protein secretion.11 Upregulation of 
GRASPs alone or ER-to-Golgi blockade could rescue the core-glycosylated ΔF508-CFTR 
transport to the cell surface of eukaryotic cells. Moreover, it has been shown that GRASP55 
overexpression could rescue the defects caused by ΔF508-CFTR mutation in murine CF 
model.10 Nevertheless, the precise machinery that the core-glycosylated CFTR could be 
survived from ER retention and then exports from the ER has not been identified.
The Golgi matrix proteins GRASPs including GRASP65 and GRASP55 were firstly 
identified as Golgi stacking factors12-14 and also regulate Golgi ribbon formation.15 Previous 
research proposed that yeast and drosophila homologues of GRASPs, Grh1 and dGRASP 
respectively, are dispensable for organizing conventional ER-to-Golgi secretory 
pathway.16,17 And GRASP65/55 were characterized as a negative regulator of exocytic 
transport.18 However, GRASPs specifically associate with cargo molecules through their 
PDZ domains and relieve the misfolded proteins from ER and facilitate them travel through 
the Golgi-independent route to the cell surface.10 Starvation induced unconventional 
secretion of AcbA, the homologue of Acyl coenzyme A (CoA) binding protein in 
Dictyostelium discoideum, also requires GRASP (Grh1) and autophagosome formation.19,20
Additionally, biogenesis of these unconventional protein secretion compartments initiates
from Grh1 (GRASP homologue in Saccharomyces cereviae) recruiting to unique membrane 
structures of ER.21
The export of secretory proteins from the endoplasmic reticulum (ER) is mediated by 
COPII-coated vesicles that bud from specific locations on the ER membrane named ER exit 
sites (ERES).22 COPII assembly starts with the activation of the small GTPase Sar123 which 
is catalyzed by Sec12 and completes with sequential recruitment of the Sec23-24 dimer to 
form the inner layer and the later assembling of Sec13-31 dimer to compose the outer layer 
of the COPII coat.24,25 Sec16 is a large peripheral membrane protein of ~240KDa tightly 
associated with ERES and is proposed to act as a scaffold for assembly of COPII by 
interacting with multiple COPII components Sec23, Sec24, Sec13, Sec31 as well as Sar1 
GTPase 26,27 and mediates the biogenesis of the ERES.28 Human Sec16 is encoded by two 
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orthologue genes including Sec16A and Sec16B and Sec16A can be seen as the primary 
orthologue as it is most similar to Sec16 (~240KDa, in size) of other species. The robust 
localization of Sec16A due to its high charged region and it localizes at the ERES
independently of downstream COPII proteins.29 As a key regulator of ERES and COPII 
vesicle biogenesis, Sec16A controls the number of ERES via an ERK-2 dependent manner.30
In order to adapt to the cargo load increment in the ER lumen, ERES number increases
together with Sec16A level. Interestingly, inositol-requiring enzyme 1 (IRE1) mediated 
unfolded protein response (UPR) was reported to regulate Sec16A for manipulating this 
adaptive response of ERES.31 The UPR is triggered by ER stress sensors containing IRE1α, 
PERK, and ATF6.32 Importantly, IRE1-mediated signaling also has been shown involved in 
the GRASP-mediated surface trafficking of ΔF508-CFTR.10
Results of the initial RNA interference (RNAi) screening of COPII-associated 
components showed that depletion of Sec16A reduced the unconventional secretion of wild-
type CFTR and ΔF508-CFTR induced by ER-to-Golgi blockade but other COPII 
components did not. Then we examined the role of Sec16A in the unconventional secretion 
pathway and identified that Sec16A plays a critical role in GRASP-mediated and ER stress 
induced unconventional secretion of core-glycosylated ΔF508-CFTR. These results provide 
new insights into the scaffolding role of Sec16A in formation of unconventional secretory 
vesicles and in the initiation of misfolded proteins export from ER to start the Golgi-bypass 
travel. Our findings provide a novel insight that Sec16A plays as a common platform for 
both conventional and unconventional export of secretory proteins from the ER.
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II. MATERIALS AND METHODS
1. Cell line and Cell culture, Plasmids, Transfection, gene silencing and chemicals
HEK293 cells and HeLa cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM high glucose) containing 10% fetal bovine serum (FBS) and penicillin (50 IU/mL)/ 
streptomycin (50 μg/mL) (all from Invitrogen) in 5% CO2 incubator at 37 °C. The 
mammalian expression plasmid Sec16A-Myc/DDK (plasmid # RC223625) was purchased 
from OriGene. The plasmids encoding human ΔF508-CFTR, Myc-GRASP55, HA-Arf1-
Q71L, Myc-Sar1-T39N, extracellular tagged HA-CFTR and HA-ΔF508-CFTR were 
described previously.10 cDNAs of no-tagged GRASP55 were subcloned into pCMV-
SPORT6 vector and cDNA of GRASP55-Myc was subcloned into pCMV-myc vector. Flag-
tagged dynamin2-K44A was generated by a PCR-based site directed mutagenesis after 
constructing pcDNA3.1(+)-hDynamin2 using a cDNA fragment amplified from HEK293 
cells (gene ID:1785, 2613 bp). pEYFP-ER plasmid was purchased from BD Biosciences 
(San Jose, CA, USA). Plasmid DNA transfection into HEK293 cells or HeLa cells were 
performed using TransIT-X2 Dynamic Delivery System (Mirus Bio LLC). siRNA duplexes 
were transfected into the HEK293 cells using Lipofectamine 2000 reagent (Invitrogen) 
according to the manufacturer’s protocol. ON-TARGETplus human Sec16B-siRNA, 
Sec23A-siRNA, Sec23B-siRNA, Sec24A-siRNA, Sec24B-siRNA, Sec24C-siRNA,
Sec24D-siRNA, Sec31B-siRNA and IRE1α-siRNA were purchased commercially 
(SMARTpool; Dharmacon, Lafayette, CO, USA). Synthesis of the following double strand 
siRNAs: siRNA against human Sec16A (targeting the sequence 
CCAGGTGTTTAAGTTCATCTAdTdT); siRNA against human Sec13 (targeting sequence 
GCACTCATGTTACGAGGAAdTdT); siRNA against human Sec31A (targeting sequence 
AACAGACAAGTTCAGCATATT dTdT) were customized as the sequences (Bioneer, Co, 
Korea). For improving the co-efficiency of knockdown and gene expression, plasmid DNA 
delivery was performed 24 hr after the siRNA transfection. Thapsigargin and Dynasore 
were commercially purchased (Sigma Aldrich, Co. LLC). 
2. Antibodies
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Antibodies were from the following sources: anti-Sec16A (KIAA0310), anti-Sec24B and 
anti-Sec24D (Bethyl Laboratories, INC); anti-Sec31A (BD Transduction Laboratories), anti-
IRE1α, anti-myc and anti-HA (Cell Signaling Technology, Danvers, MA); anti-Flag M2, 
anti-γ-tubulin (Sigma); anti-Calnexin mouse monoclonal, anti-GRASP55 rabbit polyclonal 
(Abcam, Cambridge, MA); anti-GRASP55 monoclonal (Novus Biologicals, LLC); anti-
Aldolase A, anti-ß-actin (Santa Cruz Biotechnology, SantaCruz, CA); and anti-CFTR M3A7 
(Millipore, Billerica, MA). The anti-R4 polyclonal antibody was raised against peptides 
corresponding to amino acids at 1458-1471 of human CFTR as previously reported.33
3. Immunoprecipitation, Surface biotinylation and Immunoblotting
Immunoblotting and Immunoprecipitation were performed as described previously.10
HEK293 cells transfected with appropriate plasmids were homogenized in lysis buffer 
containing 25 mM Tris (pH 7.4), 1% (v/v) NP40, 150 mM NaCl, 5% glycerol, and 1 mM 
EDTA (Roche, Applied Science, Mannheim, Germany). For co-immunoprecipitation, cell 
lysates (1,000 μg protein) were diluted to a final volume of 500 μL in lysis buffer and pre-
cleared with control Agarose Resin (crosslinked 4% beaded agarose) for 2 h at 4 °C. To 
avoid co-elution of the antibody heavy and light chains that may have co-migrated with the 
GRASP55 bands, we immobilized 10 μg affinity-purified rabbit anti-Sec16A (KIAA0310) 
antibody or normal rabbit IgG (Santa Cruz Biotechnology, SantaCruz, CA) to AminoLink 
Plus Coupling Resin (Pierce Co-Immunoprecipitation Kit, Pierce, Rockford, IL, USA) at 
room temperature for 2 hr. To precipitate endogenous Sec16A, pre-cleared protein 
complexes were collected with antibody-coupled resin overnight at 4 °C and then washed 
five times with the lysis buffer; the immune complexes were eluted with 30 μL elution 
buffer (pH 2.8) containing primary amine and 5× lane-marker sample buffer (0.3 M 
Tris•HCl, 5% SDS, 50% glycerol, lane-marker tracking dye; pH 6.8) containing 100 mM 
DTT. Protein bands were detected by enhanced chemiluminescence, and the densities of the 
bands were quantified using imaging software (Multi Gauge ver. 3.0; Fujifilm, Tokyo, 
Japan). 
The surface biotinylation assay was performed as previously described.10 HEK293 cells 
- 7 -
were transfected with appropriate plasmids and after 48 hr, cells were washed with 
phosphate buffered saline (PBS) containing 0.1mM CaCl2 and MgCl2 (PBS-CM plus), and 
then incubated with 1 mL biotin solution (0.3 mg/mL EZ-Link Sulfo-NHS-SS-Biotin in cold 
PBS-CM plus, Thermo Pierce) for 30 min at 4 °C. Cells were incubated with quenching 
buffer containing 0.5% bovine serum albumin (BSA) for 10 min and then washed three 
times with PBS. After cell lysis, the lysates were centrifuged at 16,000 g for 20 min at 4 °C. 
Resulting supernatant containing equal amount of total protein was incubated with 200 μL
10% Streptavidin agarose (Thermo Pierce). Streptavidin-bound biotinylated proteins were 
centrifuged and washed five times with lysis buffer and then eluted in 2x sample buffer. The 
following steps of the biotinylation assay were the same as for the immunoblotting 
procedure described above. 
4. Immunocytochemistry, Confocal Microscope image acquisition and 
morphometric analysis
Immunocytochemistry were performed as previously reported.10 HeLa cells were cultured 
on 18 mm round coverslips and fixed with -20 °C methanol for 6 min at -20 °C. The fixed 
cells were washed three times with PBS and then were incubated with blocking solution 
containing 5% horse serum, 1% BSA and 0.1% gelatin in PBS for 1 hr at room temperature. 
After the blocking step, cells were stained by incubating with appropriate primary 
antibodies and the treated with fluorophore-dye conjugated secondary antibodies. In the 
case of immunostaining of surface expressed protein, cells were fixed with 4% 
formaldehyde for 6 min at room temperature without permeablization and then stained with 
primary and secondary antibodies. Fluorescence images were captured using a laser 
scanning confocal microscope (LSM 780; Carl Zeiss, Berlin, Germany). Images were 
scanned using a 63x 1.4 numerical aperture (NA) oil objective lens. For distinguishing 
subcellular localization pattern of the cells in ER-Stress or GRASP-overepxressed condition 
from the control cells, zoom factor of 1 was used.
Morphometric analysis of the captured confocal images was performed by using 
MetaMorph Microscopy Analysis Software (version 7.1; Molecular Devices, Sunnyvale, 
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USA). For quantification of images under each condition, 24-bit confocal images containing 
red, green and blue components were primarily converted into three 8-bit mono-channel 
images. For the quantification of surface CFTR intensity, pixels above threshold level of  
60 were defined as CFTR. The intensity profile of each single cell was presented as the 
standard deviation around the mean of the average intensity value for the entire region. For 
the analyses of the Sec16A distribution, the high-resolution images of Sec16A punctates 
were smoothed using a low-pass filter in MetaMorph, and pixels above the threshold level 
of 30 were defined as Sec16A (+). The regions of the total cell area were determined by the 
trace region tools of MetaMorph using the differential interference-contrast images of the 
cells, then the ratio of the Sec16A (+) area versus the total cell area was calculated. The 
distribution of Sec24 was analyzed by the same method.
The degree of colocalization between Sec16A and ER markers (or GRASP55) was 
quantified based on MCC (Manders’ Colocalization Coefficients)34 using the colocalization 
module of the ZEN 2012 software (black edition; Carl Zeiss, Berlin, Germany). For the 
measurement of MCC under each condition, pixels above the fluorescence threshold level of 
both channels (red and green) 50 were defined as the overlapping signals. Then, the average 
of MCC obtained from the regions of interest was calculated. For two target proteins, 
represented as Sec16A and ER, two different MCC values were calculated as:
         	           	    	  /     	       =
∑    16  ,        
∑    16   
     	           	    	      /     	   =
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5. Internalization assay
The internalization of cell surface CFTR was performed as previously described.35
HEK293 cells were transfected with plasmids encoding CFTR and co-transfected with or 
without Flag-dynamin2-K44A. After 48 hr, cells were biotinlyated with EZ-Link sulfo-
NHS-SS-biotin (0.3 mg/mL in PBS-CM) for 30 min at 4 °C. Then the cells were warmed to 
37 °C for the indicated times to induce internalization of surface proteins. Subsequently, the 
biotin of sulfo-NHS-SS-biotinlyated proteins were stripped by washing with the sodium 2-
- 9 -
mercaptoethanesulfonate (MESNA) stripping buffer (50 mM MESNA, 150 mM NaCl, 1 
mM EDTA, 0.2% BSA and 20 mM Tris of pH 8.6) for 15 min for four times. After washing 
for three times with PBS, the cells were lysed with lysis buffer and then were centrifuged at 
16,000 g for 20 min at 4 °C. Resulting supernatant containing equal amount of total protein 
was incubated with 200 μL 10% Streptavidin agarose (Thermo Pierce) overnight at 4 °C
with gentle agitation. Streptavidin-bound biotinylated proteins were centrifuged and washed 
five times with lysis buffer and then eluted in 2x sample buffer. The following steps of the 
biotinylation assay were the same as for the immunoblotting procedure described above. 
6. Immunogold labeling and Transmission electron microscopy (TEM)
HeLa cells were fixed and performed with cyroimmuno-EM labeling as described in 
Martinez-Menárguez et al.36 HeLa cells were grown in 100mm dish were transfected with 
HA-Arf1Q71L plasmid or empty plasmid and after expressed for 18 hr, cells were fixed 
with 4% paraformaldehyde and 0.1% glutaraldehyde in PBS buffer (pH 7.4) at 4℃ for 
20min. The fixed cells were embedded in 10% gelatin and small blocks were infused 
overnight with 2.3M sucrose. Finally, frozen were performed in liquid nitrogen. For electron 
microscopy studies, 50 nm ultrathin cyrosections were cut at -120 °C using a Leica UCT7 
cyro-ultramicrotome (Leica, Vienna, Austria). Ultrathin sections were transferred from the 
diamond knife onto Formvar-coated copper slot grids using 2.3 M sucrose: 2% 
methylcellulose (1:1). Rabbit polyclonal GRASP55 antibody (Abcam, diluted 1:50) was 
used as primary antibody and to detect primary antibody, Protein A-10nm gold conjugate 
(from Dept. of Cell Biology, Utrecht School of Medicine, Utrecht, Netherlands) was used. 
Both GRASP55 antibody and Protein A gold were diluted in 0.1% BSA-c (Aurion, 
Netherlands) in PBS. For immunogold labeling experiments, the ultrathin cryosections were 
firstly blocked with 0.1% cold fish gelatin and 5% BSA for 10min and then were incubated 
with GRASP55 antibody for 30min, continually were incubated with protein A-gold for 30
min. The grids were stained in 4% neutral uranyl acetate and embedded in 2% 
methylcellulose containing 0.3% uranyl acetate as previously described.37 Immuno-electron 
microscopy was conducted as examining the grids at 120 kV using a Tecnai G2 Spirit Twin 
Transmission Electron Microscopy (FEI Company, USA). 
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7. Quantitative real-time PCR (qPCR)
Purified RNA samples from HEK293 cells which endogenous Sec23A, Sec24A, Sec13A 
were silenced with specific siRNA were reverse-transcribed using RNA to cDNA EcoDry™ 
Premix (Clontech Laboratories, Takara Bio company). The total reaction volume was 
adjusted to 20 μL with RNase-free water after mixing 100 ng cDNA, 1 μL forward primer 
and 1 μL reverse primer for each, 10 μL 2x SYBR premix Ex Taq and 0.4 μL 50x ROX 
reference dye (Takara Bio Inc). Amplification was performed under the following cycling 
conditions: 95 °C for 15 min followed by 40 cycles of 95 °C for 15 sec and 60 °C for 40 sec. 
Triplicate analyses were performed for each cDNA. Relative mRNA expression levels were 
calculated via the comparative threshold cycle (Ct) method with GAPDH as control as 
follows: ΔCt= Ct (GAPDH)-Ct (target gene). The fold-change in gene expression normalized 
to GAPDH and relative to the control sample was calculated as 2-ΔΔCt.
8. Biological and technical replication
Biological replicates are parallel measurements of biologically distinct samples that 
capture random biological variation. The samples for each biological replicate were 
prepared from cells grown at different times. Technical replicates are repeated 
measurements of the same sample of each biological replicate.
In the case of western blot data, almost the whole amount of proteins from one biological 
replicate was used for surface biontinylation assay or immunoprecipitaton assay. Therefore, 
only one technical replicate was performed for each biological replicate. The sample size 
described above refers to the number of biological replicates. In the case of qRT-PCR 
experiments, three equal-sized aliquots of cDNA from the same biological replicate are used 
as the template in individual PCR reactions. For each biologically distinct condition, 
average value of technical replicates was computed as a single data point of one biological 
replicate. The sample size described above refers to the number of biological replicates. In 
the case of immunofluorescence experiments, at least five biological replicates were used. 
For each biological distinct condition, images from 5-10 cells were averaged and used for 
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the single data point of statistical analyses. 
9. Criteria for exclusion/inclusion of data
The outlier data are not ‘errors’ but just the observations are distant from the mean of 
observations. In the present study, once the correct experimental conditions were confirmed 
(e.g. expression of HA-Arf1-Q71L or knockdown of Sec16A in western blotting of cell 
lysates), not any outlier data was excluded.
10. Statistical analysis
All experiments were performed at least three times independently for each condition and 
present as the mean ± SEM (standard error of the mean). Statistical analysis was performed 
using Student’s t-tests or with analysis of variance followed by Dunnet’s multiple 
comparison tests as appropriate; p < 0.05 was considered statistically significant.
Calculations were performed using GraphPad Prism5 software (GraphPad Software,Inc., La 
Jolla,CA).
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III. RESULTS
1. Sec16A affects both conventional secretion of CFTR and unconventional 
secretion of ΔF508-CFTR
Wild type CFTR undergoes Golgi-mediated complex glycosylation (Figure 1A, band C)
and ER-mediated core-glycosylation (Figure 1A, band B). It has been shown that ER export 
of Golgi protein GalNAc-T2-GFP was abolished by Sec16A depletion.38 Brefeldin A (BFA) 
treatment led to redistribution of GalNAc-T2-GFP to ER and returned to Golgi after BFA 
removal39 in control cells treated with nonspecific siRNA, in contrast, knockdown of 
Sec16A led to accumulation of GalNAc-T2-GFP in the juxtanuclear Golgi region38, as 
reported earlier. In an effort to identify the role of Sec16A in conventional secretion of
CFTR, RNAi-mediated knockdown of Sec16A was performed in HEK293 cells. Silencing 
of Sec16A by small interfering RNA (siRNA) strongly reduced the surface expression of 
complex-glycosylated CFTR (band C) (Figure 1A, B), indicating that ER-to-Golgi mediated 
transport of CFTR was abolished by depletion of Sec16A. Moreover, surface expression of 
core-glycosylated immature form of CFTR which was transported through Golgi-bypass 
unconventional secretion pathway was also inhibited by silencing of Sec16A (Figure 1A, 
lane 3-4). Arf1-Q71L is a dominant negative mutant of COPI component restricted to GTP-
bound form. Expression of Arf1-Q71L could induce ER-to-Golgi blockade40,41 resulting in 
unconventional secretion of core-glycosylated CFTR to the cell surface.10 In contrast, the 
surface expression of ΔF508-CFTR (Figure 1C, lane 3) under the condition of Arf1-Q71L
induced ER-to-Golgi blockade was abolished by depletion of Sec16A by siRNA (Figure 1C, 
lane 4). In order to rule out the possibility that these rescue events were resulted from 
internalization, we examined the surface expression of core-glycosylated CFTR with 
treatment of dynamin inhibitors including dynasore and the dominant-negative mutant of 
dynamin (dynamin2-K44A) to inhibit the protein endocytosis process.42,43 Results of the 
internalization assays showed that treatment of dynasore (80 μM, 12 hr) (Figure 4B) and 
expression of dynamin2-K44A (Figure 4C) reduced the internalization of wild-type CFTR. 
Even though these treatment induced an increment in cell-surface expression of transferrin 
receptor and complex-glycosylated wild-type CFTR (Figure 5A, B), dynasore treatment and 
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dynamin2-K44A expression neither resulted in cell-surface expression of core-glycosylated 
CFTR nor interfered the Arf1-Q71L-mediated unconventional secretion of ΔF508-CFTR
(Figure 5C, D). 
As an additional and verification approach, we also investigated the function of core 
COPII components in the secretion of ΔF508-CFTR by RNAi screening. Sec23-24 and 
Sec13-31 complexes are downstream COPII coat proteins defining the later structure of ER 
exit sites (ERES) on the basis of that the platform protein Sec16A defines the tER.29 As 
shown in Figure 2, depletion of Sec16B and the isoforms of COPII components including 
Sec23, Sec24, Sec13 and Sec31 siRNA do not alter the Arf1-Q71L-mediated cell-surface 
expression of ΔF508-CFTR. The knockdown efficiency of siRNAs was confirmed through 
quantification of the mRNA or protein expression of each target gene by quantitative real-
time PCR and immunoblotting (Figure 3). These results altogether demonstrate that Sec16A 
is the unique element which was responsible for both conventional and unconventional
secretion of CFTR.
Next, we confirmed the role of Sec16A in surface expression of CFTR and ΔF508-CFTR 
by using the immunocytochemistry approach. For morphological analysis, in order to 
prevent the cells from deranging or losing during the immunocytochemistry, HeLa cells 
were utilized instead of HEK293 cells taking advantage of the feature of HeLa cells could 
attach more firmly to coverslips. HeLa cells were firstly transfected with scrambled or 
Sec16A-specific siRNA, after 24 hr, HA tagging at the extracellular loop of wild type-CFTR 
or ΔF508-CFTR were transiently transfected and then were expressed for another 24 hr. 
Subsequently, non-permeabilized fixation was performed with 4% paraformaldehyde for 6 
min at room temperature to circumvent the possibility of destruction of membrane integrity. 
HA-epitopes exposed at the cell surface would be labeled and the surface expressed CFTR 
or ΔF508-CFTR could be detected. In control cells expressing wild type-CFTR, surface 
expressed CFTR were detected in non-permeabilized cell membrane (Figure 6A, green 
fluorescence image). In accordance with the surface biotinylation result (Figure 1A, lane1), 
ΔF508-CFTR could not reach the plasma membrane in normal condition based on non-
fluorescence signal in the cell surface (Figure 6B) despite ΔF508-CFTR expression could be 
- 14 -
detected by anti-R4 antibody staining after membrane was permeablized (Figure 6B, red 
fluorescence image) after the surface staining with anti-HA antibody was completed. On the 
contrary, when the ER-to-Golgi conventional secretion was blocked by expression of 
dominant negative mutant Sar1-T39N which is the GDP-restricted Sar1 GTPase,44 surface 
expressed ΔF508-CFTR could be observed in non-permeabilized cells (Figure 6C, green 
fluorescence image). However, the ER-to-Golgi blockade mediated rescue of ΔF508-CFTR 
was notably reduced by silencing of Sec16A by siRNA (Figure 6D, E). In a word, these 
results indicate that Sec16A is required for the unconventional secretion of CFTR but the 
other COPII components are not needed.
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Figure 1. Sec16A-depletion inhibited the surface expression of both complex-glycosylated 
CFTR and core-glycosylated CFTR. Surface biotinyation of CFTR or ΔF508-CFTR. (A, C) 
Proteins extract from HEK293 cells were firstly transfected with equal amount of control 
scrambled siRNA or Sec16A-specific siRNA (150 nM), after 24 hr, transfected with wild type (A)
or ΔF508-CFTR (C). Arf1-Q71L overexpression was used to block the ER-to-Golgi conventional 
trafficking. Surface-biotinlyated proteins and the whole proteins were immunoblotted with anti-
Sec16A, anti-M3A7 and anti-HA antibodies. In each experiment, cell surface specific labeling of 
proteins was confirmed by the absence of cytosolic protein AldolaseA in biotinlyated fraction. 
RNAi-mediated knockdown of Sec16A abolished conventional surface secretion of WT-CFTR 
(A). Surface expression of immature core-glycosylated b form of  WT-CFTR (A) or ΔF508-
CFTR (C) were also reduced by silencing of Sec16A under the condition of Arf1-Q71L 
overexpression induced blockade of conventional ER-to-Golgi traffic. Multiple experiments (n=4) 
are summarized in (B, D). Surface-proteins versus cell lysates were quantified and data were 
shown as mean ±SEM. **p < 0.01, ***p < 0.001, ns: no significant differences. band B: immature 
ER core-glycosylated CFTR; band C: mature complex-glycosylated CFTR. See Table 1-2 for 
sample size, replication and statistical information.
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Figure 2. COPII core components are not required for Arf1-Q71L-induced cell-surface 
expression of ΔF508-CFTR. (A, B) Representative surface biotinylation assays of single gene 
knockdown. The ER-to-Golgi blockade induced unconventional secretion of ΔF508-CFTR was 
not affected by knockdown of COPII component proteins. Surface biotinylation was performed 
after transfection with control scrambled siRNA or siRNAs specific for Sec16, Sec23, Sec24, 
Sec13 and Sec31 (150 nM for each). Results of multiple experiments are summarized in (C). (D) 
Representative surface biotinylation assays of the combinatorial gene knockdown on the same 
gene family. Results of multiple experiments are summarized in (E). Data are shown as mean 
±SEM. ***p < 0.001. See Table 1-2 for sample size, replication and statistical information.
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Figure 3. Validation of siRNAs targeting Sec16A and core COPII components (A, B) HEK293 
cells were transfected with each siRNA for 48 hr and then protein samples were prepared. A 70–
90% depletion of Sec16A (A, mean ± SEM, n = 3) and Sec31A (B, mean ± SEM, n = 3) was 
confirmed by immunoblotting, (C) Validation of each siRNA was performed by quantitative real-
time PCR based mRNA quantitation. Single gene siRNAs specifically targeting human isoforms of 
Sec16 and all core COPII components including Sec23, Sec24, Sec13, and Sec31 were transfected 
to HEK293 cells for 48 hr and then RNA samples were extracted from the cells under each 
condition. (D-G) Validation of siRNAs under conditions of multiply knockdown of Sec16 and 
COPII components on the same gene family was performed by quantitative real-time PCR based 
mRNA quantitation . (mean ± SEM, n = 3). **p < 0.01. See Table 1-2 for sample size, replication 
and statistical information.
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Figure 4. Internalization of CFTR was inhibited by dynamin inhibitors. (A-C) The 
internalization assay of cell surface CFTR was performed in HEK293 cells with or without (A)
dynamin inhibitors including dynasore (80 μM, 12 hr) treatment (B) or expression of dynamin2-
K44A (C). Dynasore and dynamin2-K44A are inhibitors of the dynamin-mediated internalization. 
Cell surface proteins were biotinylated and then internalized for indicated times at 37 °C. Proteins 
remaining at the cell surface were stripped of biotin with MESNA stripping buffer. (D)
Quantification of results of multiple experiments (mean ± SEM, n = 3) are summarized. **p< 0.01, 
***p< 0.001. See Table 1-2 for sample size, replication and statistical information.
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Figure 5. Arf1-Q71L-induced surface expression of core-glycosylated CFTR is not influenced
by inhibition of internalization. HEK293 cells were transfected with plasmids expressing 
transferrin receptor or CFTR, and a surface biotinylation assay was performed 24 hr after 
transfection. (A) Cell-surface expression of transferrin receptor (Rc) was increased by dyasore and 
dynamin2-K44A. (B) Surface expression of band C form of wild-type CFTR was increased by 
dynasore treatment; however, the Arf1-Q71L-mediated surface expression of band B form of wild-
type CFTR was not affected. (C) Dynasore and (D) dynamin2-K44A neither induced the surface 
expression of ΔF508-CFTR, nor influenced the Arf1-Q71L –induced surface expression of ΔF508-
CFTR. Quantification of results of multiple experiments are summarized under each blot. ***p < 
0.001, n.s.: not significant. See Table 1-2 for sample size, replication and statistical information.
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Figure 6. Silencing of Sec16A inhibits unconventional trafficking of ΔF508-CFTR to the cell 
surface. (A-D) Representative immunofluorescence images of wild-type (WT) or ΔF508-CFTR.
Non-permeabilized immunostaining of surface expressed CFTR was performed. After Sec16A 
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2. Requirement of Sec16A in GRASP-mediated unconventional secretion of ΔF508-
CFTR
Given recent evidences showed that overexpression of GRASPs could also activate the 
unconventional secretion of ΔF508-CFTR.10 Furthermore, we investigated whether Sec16A 
is also involved in GRASP-mediated unconventional secretion pathway. Three different 
kinds of plasmids encoding GRASP55 including Myc-tagging at the N-terminus of 
GRASP55, Myc-tagging at the C-terminus of GRASP55 and GRASP55 without any tag 
were co-transfected with ΔF508-CFTR to HEK293 cells after Sec16A siRNA was
transfected and expressed for 24 hr. Depletion of Sec16A by small interfering RNA 
significantly reduce the surface expression of ΔF508-CFTR which was induced by 
overexpression of GRASP55 (Figure 7), suggesting that Sec16A plays a significant role in 
establishment of the platform for initiating GRASP-mediated unconventional secretion of 
ΔF508-CFTR.
To elucidate the platform role of Sec16A in GRASP-mediated unconventional secretion 
siRNA was transfected and expressed for 24 hr, DNA plasmids of HA-tagged at the extracellular 
loop of CFTR or ΔF508-CFTR were transfected to HeLa cells. The cells were stained with HA 
antibody after 4% paraformaldehyde fixation without permeabilization procedure. Following the 
surface staining of CFTR (green), treatment of the same cells with methanol was performed to 
permeablize both plasma membrane and intracellular membranes. The cells were stained with anti-
R4 antibody to confirm the expression of CFTR or ΔF508-CFTR (red). Sar1-T39N were stained 
with anti-myc antibody and showed as grey pseudo color image. WT-CFTR well expressed on the 
surface (A), in contrast, ΔF508-CFTR was retained in the ER (B). When ER-to-Golgi was blocked 
by Sar1-T39N, ΔF508-CFTR was rescued to the cell surface (C). However, silencing of Sec16A by 
siRNA abolished the surface expression of ΔF508-CFTR (D). (E) Quantification of surface CFTR 
intensity. Data are shown as mean ± SEM from three independent experiments (each comprising 
analysis of 20-30 cells). Arrows indicate surface expressed CFTR or ΔF508-CFTR. Arrowheads 
indicate the cells do not express surface CFTR. Scale bar, 10 μm. ***p < 0.001. See Table 1-2 for 
sample size, replication and statistical information.
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pathway, immunoprecipiatation assay was performed to assess the protein-protein 
interaction between GRASP55 and Sec16A. When co-expressed in HEK293 cells, 
GRASP55 weakly interacted with Sec16A in normal condition (Figure 8A, line 2). However, 
interaction between Sec16A and GRASP55 was enhanced significantly when ER-to-Golgi 
blockade was induced by Arf1-Q71L expression (Figure 8A, B). Taken together, we can 
make a conclusion that assembly of large complexes containing GRASP55 and Sec16A
would be enhanced by ER-to-Golgi blockade to initiate the formation of unconventional
secretion vesicles transporting ΔF508-CFTR.
Figure 7. Depletion of Sec16A inhibited GRASP-mediated unconventional secretion of ΔF508-
CFTR. (A) Surface biotinylation of ΔF508-CFTR. HEK293 cells were transfected equally with 
scrambled siRNA or Sec16A siRNA 24 hr before transfection of plasmids encoding ΔF508-CFTR 
and GRASPs. After 48 hr, surface biotinylation was performed. Overexpression of three different 
variants of GRASP55 (including Myc tagging at N-terminus of GRASP55, Myc tagging at C-
terminus of GRASP55 and GRASP55 without any tag) induced cell surface expression of ΔF508-
CFTR. Sec16A depletion diminished GRASP55-mediated surface rescue of ΔF508-CFTR. (B) 
Surface-proteins versus cell lysates were quantified and multiple experiments are summarized. 
Data are shown as mean ± SEM (n=3). ***p < 0.001. See Table 1-2 for sample size, replication and 
statistical information.
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3. Sec16A re-localizes and co-localizes with GRASP55 during the unconventional
secretion of ΔF508-CFTR
To investigate the relationship between GRASP55 and Sec16A, we examined the 
subcellular localization of GRASP55 and Sec16 in HeLa cells. Previous research showed 
that in Drosophila S2 cells, dGRASP localizes both to Golgi membranes and the ER exit 
sites.45 When it comes to mammalian model, in control HeLa cells, Sec16A displayed 
typical ERES localization that mainly concentrated adjacent to the nucleus but only a
minority of puncta dispersed in the peripheral area, and GRASP55 showed typical 
perinuclear ribbon-like structure of the Golgi apparatus (Figure 9A). Nevertheless, 
GRASP55 redistributed overall the whole cell increasing the colocalization with puncta of 
Figure 8. Protein-protein interaction between Sec16A and GRASP55 was increased by ER-
to-Golgi blockade. (A-B) The Co-immunoprecipitation experiments with Sec16A and 
GRASP55 were performed in HEK293 cells. Protein samples were precipitated with anti-
Sec16A (KIAA0310) and blotted with anti-GRASP55. A representative coimmunoprecipitation 
result is shown in (A), and fold change relative to control was quantified and results of multiple 
experiments (n = 3) are summarized in (B). ER-to-Golgi blockade induced by Arf1-Q71L 
increased the association between Sec16A and GRASP55. ***p < 0.001: difference from each 
control. See Table 1-2 for sample size, replication and statistical information.
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Sec16A especially in the peripheral region when ER stress was induced by treatment of 
thapsigargin which depletes calcium storage in the ER lumen (Figure 9B) and co-expression 
with Arf1-Q71L or Sar1-T39N which induces ER-to-Golgi blockade. (Figure 9C, D).
Furthermore, transmission electron microscopy (TEM) observation supported that Arf1-
Q71L induced ER-to-Golgi blockade results in redistributing of Golgi protein GRASP55 
from the Golgi to the ER, in which the ERES protein Sec16A localizes (Figure 10).The 
relocalization of Sec16A accompanying with GRASP55 in response to ER stress raises a 
question whether Sec16A opens the gate for GRASP55 to mediate the unconventional 
secretion of ΔF508-CFTR.
Next, to identify the role of Sec16A in the unconventional ΔF508-CFTR secretion, we 
compared the cellular localization of Sec16A, GRASP55 and ΔF508-CFTR under various 
conditions stimulating unconventional secretion of ΔF508-CFTR. Arf1-Q71L induced 
blockade of ER-to-Golgi resulted in the surface expression of ΔF508-CFTR in HeLa cells 
(Figure 11A, B). Moreover, the localization of Sec16A got changed by Arf1-Q71L. Sec16A 
puncta mainly concentrated in the juxtanuclear region (Figure 11A and HA-negative cells in 
Figure 11C, arrowheads) in normal condition, in contrast, Sec16A puncta dispersed into 
more peripheral regions (Figure 11B and HA-positive cells in Figure 11C, arrows) when the 
ER-to-Golgi transport was blocked by Arf1-Q71L and the Sec16A puncta appeared in > 80% 
of the cytoplasmic area (Figure 11D). These results are comparable with a recent finding 
which reported that ER relocalization of GRASP is a requisite for unconventional secretion 
of ΔF508-CFTR.46 What’s more interesting, in HeLa cells with a high level of GRASP55-
Myc expression, which induces unconventional secretion of ΔF508-CFTR (Figure 13B), the 
puncta of Sec16A and GRASP55 were noticeably redistributed to the whole cell area 
(Figure 12C, arrows). In contrast, in the cells with a low level of GRASP55-Myc expression, 
which does not induce unconventional secretion of ΔF508-CFTR (Figure 13A), GRASP55 
expressed at the typical perinuclear Golgi apparatus (Figure 12B) and the puncta of Sec16A 
mainly concentrated in the typical perinuclear ERES region to facilitate conventional ER-to-
Golgi transport (Figure 12A, B). Additionally, immunofluorescence colocalization analyses
which assesse the pixel colocalization correlation between Sec16A and ER markers (ER-
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YFP and calnexin) revealed that the relocalized Sec16A puncta were highly colocalized with 
the ER-marker proteins, suggesting that Sec16A relocalized to the peripheral ER area 
(Figure 14). The peripheral localization of Sec16A increased Manders’ Colocalization
Coefficient (MCC) due to an increment in the co-incident coefficient between the fractions 
of Sec16A and ER marker proteins (Figure 14C, G). Altogether, ER-to-Golgi blockade and 
GRASP55 overexpression stimulate the localization change of Sec16A and GRASP55 and 
facilitate the assembly of large complexes containing Sec16A, GRASP55 and ΔF508-CFTR.
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Figure 9. Colocalization of Sec16A and GRASP55. (A–D) The cellular localization of Sec16A 
and GRASP55 was analyzed using immunocytochemistry in HeLa cells. Representative 
immunofluorescence images are shown. Endogenous GRASP55 was labeled with fluorophore-
tagged antibodies (green), and Sec16A was labeled with fluorophore-tagged antibodies (red). 
Some cells were cotransfected with Arf1-Q71L (C) or Sar1-T39N (D) to induce ER-to-Golgi 
blockade. The induction of ER stress (thapsigargin) (B) or ER-to-Golgi blockade (Arf1-Q71L or 
Sar1-T39N) significantly increased the colocalization of Sec16A and GRASP55 in both the 
perinuclear (green box) and the peripheral (red box) regions. (E) Quantification of multiple 
experiments (mean ± SEM, n = 5, each comprising analyses of 5–10 cells) analyzing the 
Manders’ colocalization coefficient (MCC) of fraction of Sec16A in compartments containing 
GRASP55 are summarized. The precise analysis procedures were described in the Materials and 
Methods. Scale bar: 10 μm, ***p < 0.001: difference from each control. See Table 1-2 for 
sample size, replication and statistical information.
Figure 10. Electron Microscope observation of the immunogold labeled GRASP55. 
Transmission electron microscopy (TEM) observation showed the localization of GRASP55 in 
normal condition (A) and in Arf1-Q71L induced ER-stress condition (B). GRASP55 (10 nm 
gold particles) was immunolabeled on the ultrathin cryosections of HeLa cells. GRASP55 
immunogold particles were found on the Golgi membrane (arrowhead) in the control cells (A).
Arf1-Q71L induced ER-to-Golgi blockade induced GRASP55 gold particles redistributed to ER 
(arrows) (B). The precise experiment procedures were described in the Materials and Methods. 
Scale bar: 200 nm.
- 27 -
Figure 11. Arf1-Q71L-induced unconventional secretion of ΔF508-CFTR was 
accompanied by localization change of Sec16A. (A, B) Representative 
immunofluorescence images of Sec16A and ΔF508-CFTR in normal condition and under 
the condition of Arf1-Q71L induced ER-to-Golgi blockade. HeLa cells were transfected 
with plasmids of HA-tagged at the extracellular loop of ΔF508-CFTR with empty vector or 
Arf1-Q71L. Before cell membrane was permeabilized, ΔF508-CFTR expressed at the cell 
surface was stained with anti-HA antibody (green). After cell membrane was 
permeabilized, total ΔF508-CFTR was stained with anti-M3A7 antibody (grey) and 
Sec16A was stained with anti-Sec16A (KIAA0310 antibody) (red). Sec16A puncta were 
localized mainly at the juxtanuclear region (arrowhead) in control cells (A) where ΔF508-
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CFTR could not reach the cell surface. Sec16A puncta were relocalized to the whole cell 
area (arrow, red) (B, C) when ER-to-Golgi blockade was induced by Arf1-Q71L expression 
and the unconventional secretion of ΔF508-CFTR was evoked (green) (B). (C, D)
Localization change of Sec16A in cells expressing Arf1-Q71L (white dotted line) was 
distinguished from that in cells without of expressing Arf1-Q71L. (C) Representative 
immunofluorescence images are shown in (C) and the morphometric analysis of multiple
experiments were summarized in (D). Data are shown as mean ± SEM (n=5, each 
comprising analyses of 5-10 cells). Scale bar: 10 μm. ***p < 0.001. See Table 1-2 for 
sample size, replication and statistical information.
Figure 12. GRASP55-mediated unconventional secretion of ΔF508-CFTR was accompanied by 
relocalization of Sec16A. (A-C) Representative immunofluorescence images showed localization
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of Sec16A in normal condition and in conditions of expression of exogenous GRASP55-Myc. HeLa 
cells were transfected with empty plasmids (A), GRASP55-Myc (low 100 ng/mL) (B) or GRASP55-
Myc (high 400 ng/mL) (C).The cells were fixed after 24 hours and then were immunostained with 
anti-Sec16A and anti-GRASP55 or anti-myc (GRASP55). Cells express exogenous GRASP55 or 
Arf1-Q71L were labeled with white dotted lines to compare with the control cells in each view of 
images. Arrows indicate the puncta of Sec16A dispersed to the periphery of the cells expressed with 
high amounts GRASP55-Myc. (D) Sec16A dispersion level was quantified as percentage of Sec16A 
(+) area versus total cell area. Results of multiple experiments (mean ± SEM, n=5~10) were 
summarized. Scale bars: 10 μm. ***p < 0.001. See Table 1-2 for sample size, replication and 
statistical information.
Figure 13. High level of GRASP55 expression mediated the cell-surface rescue of ΔF508-
CFTR. (A, B) Cell-surface expressed HA-tagged at the extracellular loop of the ΔF508-CFTR
(green) was immunolabeled with anti-HA antibodies without permeablization procedure after 
fixation of the HeLa cells with 4% paraformaldehyde. Then, after permeablization, the total 
CFTR (red) was immunostained with anti-R4 antibodies. (B) High-level expression of GRASP55-
Myc (400 ng/mL) (grey) could rescue ΔF508-CFTR to the cell surface but (A) low-level 
expression of GRASP55-Myc (100 ng/mL) (grey) was not sufficient to rescue ΔF508-CFTR. 
Arrows indicate surface expression of ΔF508-CFTR. Three independent experiments showed 
reproducible results. Scale bars: 5 μm.
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Figure 14. Sec16A relocalized within the ER region during the unconventional 
secretion. (A-B) Representative immunofluorescence images showed cellular distribution 
of Sec16A. HeLa cells were transfected with plasmids encoding the ER marker protein ER-
yellow fluorescent protein (ER-YFP) with (B) or without (A) Arf1-Q71L. (C)
Quantification results of the multiple experiments are summarized. Arf1-Q71L induced
ER-to-Golgi blockade increased the percentage of ER overlapping with Sec16A (~85%) in 
contrast to that in control conditions (~30%). A high percentage of Sec16A colocalizes with 
ER-YFP (~85%) in all conditions, and analyses using Manders’ colocalization coefficient 
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4. Sec16A relocalization is independent of COPII in response to ER-to-Golgi 
blockade and GRASP55 overexpression
To strengthen the evidence that GRASP-overexpression and ER-to-Golgi blockade
specifically alternate the distribution of Sec16A, we took a more detailed approach. We 
compared the subcellular localization of Sec31A (as a representative subunit of core COPII
component) and Sec16A (as an organizer of ERES formation) in the cells expressed with 
GRASP55-Myc at high level and Arf1-Q71L or Sar1-T39N induced ER-to-Golgi blockade
(MCC) show that ER-to-Golgi blockade increased the extent of correlation coefficient 
between ER-YFP and Sec16A. The MCC value calculating the fraction of Sec16A in 
compartments containing ER-YFP was increased to 0.75 in ER-to-Golgi blockade 
condition relative to that in control conditions (MCC = 0.30). The MCC value calculating
the fraction of ER-YFP in compartments containing Sec16A was increased to 0.97 relative 
to that in control conditions (MCC = 0.30). (D-F) Representative immunofluorescence 
images showed the cellular distribution of Sec16A. Cells were transfected with mock (D), 
GRASP55-Myc (E), or Myc-Sar1-T39N plasmids (F), and the ER marker protein calnexin
(green) was co-immunostained with Sec16A. GRASP55-Myc and Myc-Sar1-T39N (grey) 
were immunostained with anti-Myc antibody. White dotted line shows cell periphery of 
GRASP55-Myc or Sar1-T39N expressing cells. Arrows indicated the redistribution of 
Sec16A to entire cellular area by ER-to-Golgi blockade or GRASP55 overexpression. (G)
Quantification results of the multiple experiments are summarized. ER-to-Golgi blockade 
increased the percentage of ER overlapping with Sec16A (~85%) relative to that in control 
conditions (~25%). A high percentage of Sec16A colocalizes with calnexin (~75%) in all 
conditions, and the MCC analyses show that ER-to-Golgi blockade and GRASP55 
overexpression increased the extent of correlation coefficient between calnexin and 
Sec16A. The MCC value calculating the fraction of Sec16A in compartments containing 
calnexin was increased to 0.75 in GRASP55 overexpressed condition and to 0.72 in ER-to-
Golgi blockade condition, respectively, relative to that in control conditions (MCC = 0.31). 
The MCC value calculating the fraction of calnexin in compartments containing Sec16A 
was increased to 0.97 in GRASP55 overexpressed condition and to 0.97 in ER-to-Golgi 
blockade condition, respectively, relative to that in control conditions (MCC = 0.31). Data 
shown are mean ± SEM (n = 7, each comprising analyses of 5–10 cells). Scale bar: 10 μm. 
***p < 0.001: difference from each control. See Table 1-2 for sample size, replication and 
statistical information.
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(Figure 15A-D). In accordance with what happened in GRASP55 overexpressed cells or 
Arf1-Q71L expression induced ER-to-Golgi blocked cells, Sar1-T39N expression also 
induced Sec16A relocalized to > 90% of the whole cell area versus > 18% in the control 
cells (Figure 15E). Contrastively, no significant distribution alternation of Sec31A puncta
was observed in GRASP55 overexpressed and ER-to-Golgi blockade induced cells 
compared to control cells. More interestingly, Sar1-T39N expression caused the 
concentration of Sec31A to the negative end of microtubule where is also named as 
microtubule-organizing center (MTOC). The co-immunostaining of Sec31A and γ-tubulin
which is utilized as MTOC marker was performed to verify the localization of Sec31A,
(Figure 16A, B). Moreover, the cellular localization of other COPII components including
Sec24B and Sec24D was also observed in control cells and in the cells expressing Arf1-
Q71L (Figure 17A-D). Similar to that of Sec31A, the localization of Sec24 was not affected 
by ER-to-Golgi blockade (Figure 17E). Collectively, these observations suggest that the 
formation of GRASP-mediated unconventional secretion vesicles is supported by the ERES
regulator protein Sec16A but is independent of the core COPII components.
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Figure 15. Sec16A but not Sec31A relocalizes when ER-to-Golgi was block or 
GRASP55 was overxpressed. (A-D) Intracellular distribution of Sec16A and the 
representative core COPII component Sec31A was compared. The cells were fixed after 24
hr and then were immunostained with anti-Sec16A and anti-Sec31A antibodies. The 
unconventional conditions including expression of GRASP55-Myc (B), HA-Arf1-Q71L 
(C) and Myc-Sar1-T39N (D) were immunolabeled with anti-myc or anti-HA antibodies.
Sec16A dispersed to the periphery of the cells (arrows) but localization of Sec31A was not 
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Figure 16. Sec31A concentrated near the MTOC during ER-to-Golgi blockade. The 
core COPII protein Sec31A and γ-tubulin were co-stained in control cells (A) and in the 
cells expressed with Sar1-T39N to induce ER-to-Golgi blockade (B). γ-tubulin is a marker 
of microtubule-organizing center (MTOC). Sec31A was concentrated near the MTOC in 
cells with ER-to-Golgi blockade. Scale bar: 5 μm.
altered in the cells overexpressed with GRASP55 or Arf1-Q71L or Sar1-T39N (were 
labeled with white dotted line to compare with the control cells in each view of images). 
(E) Quantification results of the ratio of Sec16A (+) area or Sec31A (+) area versus the 
total cell are summarized (mean ± SEM, n ³ 5, each comprising analyses of 5–10 cells). 
Morphometric analysis was performed by MetaMorph software and at least 5 cells were 
analyzed for each condition. Scale bar: 10 μm, ***p < 0.001, difference from control cells. 
See Table 1-2 for sample size, replication and statistical information.
- 35 -
Figure 17. ER-to-Golgi blockade does not relocalize Sec24B or Sec24D. (A-D) The cellular 
localization of core COPII components Sec24B and Sec24D was confirmed in control cells and in 
cells treated with Arf1-Q71L. (E) Quantification of the ratio of the Sec24B (+) or Sec24D (+) area 
versus the total cell area in multiple experiments (mean ± SEM, n ³ 5, each comprising analyses 
of 5–10 cells) are summarized. Arf1-Q71L induced ER-to-Golgi blockade has no significant effect 
on the localization of COPII components. Scale bar: 10 μm. See Table 1-2 for sample size, 
replication and statistical information.
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5. IRE1α regulates the unconventional ΔF508-CFTR secretion by modulating 
Sec16A
To investigate the underlying machinery that Sec16A plays a scaffolding role on 
unconventional secretion, we studied whether there are any upstream signaling manipulating
Sec16A to facilitate GRASP55 rescue the ΔF508-CFTR. According to the previous findings, 
IRE1α-mediated signaling, which is a key regulator of UPR, has been identified to be 
required for ER stress-mediated and GRASP-mediated unconventional secretion of ΔF508-
CFTR.10 In order to relieve the protein burden in the ER, IRE1-dependet UPR could also be 
triggered through chronic cargo overload which resulted in neo-generation of Sec16A and 
increment of ERES number.31 IRE1α depletion led to abolishment of ER stress-mediated 
surface expression of ΔF508-CFTR. Interestingly, supplementation of Sec16A by exogenous 
transfection could rescue the mutant ΔF508-CFTR to the cell surface (Figure 18A, B). In 
accordance with the ER stress-mediated rescue results, GRASP55 overexpression induced 
rescue of ΔF508-CFTR was also inhibited by IRE1α silencing and was also recovered by 
replenishment of Sec16A (Figure 18C, D). Immunocytochemistry results further supported 
the notion that IRE1 is the upstream signal switches Sec16A expression and localization in 
“Unconventional secretion” situations (Figure 19A-D). Sec16A expression level was 
reduced in HeLa cells and the dispersion ratio of Sec16A in response to Arf1-Q71L induced 
ER-to-Golgi blockade or GRASP55 overexpression was diminished from 91% to 19% when 
IRE1α was depleted by siRNA (Figure 19E). Taken together, these results supply a logical 
clue for illustrating IRE1α-signaling is a necessary and sufficient condition for de novo
synthesis of Sec16A during the unconventional secretion of ΔF508-CFTR.
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Figure 18. IRE1α-depletion inhibits the unconventional secretion of ΔF508-CFTR by down-
regulating Sec16A.  (A-D) IRE1 knock-down abolished surface rescue of ΔF508-CFTR could 
be recovered by Sec16A overexpression. Arf1-Q71L induced (A) or GRASP55-mediated (C) 
surface expression of ΔF508-CFTR was examined in the cells pre-transfected with scrambled or 
IRE1α-specific siRNA. IRE1α depletion abolished the surface expression of ΔF508-CFTR. 
Supplementation of exogenous Sec16A recovered the surface expression of ΔF508-CFTR which 
were inhibited by IRE1α depletion. Quantification of results of multiple experiments (mean 
±SEM, n=3 ***p < 0.001) are summarized (B, D). See Table 1-2 for sample size, replication and 
statistical information.
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Figure 19. IRE1α depletion inhibited the redistribution of Sec16A. (A-D) Relocalization of 
Sec16A in cells overexpressed with GRASP55 or Arf1-Q71L were down-regulated by silencing of 
IRE1α. Cells overexpressed with GRASP55 or Arf1-Q71L were labeled with white dotted line. 
Sec16A dispersed to periphery of the cells (arrows) in the cells overexpressed with GRASP55-Myc 
or Arf1-Q71L. Dispersion of Sec16A in response to unconventional secretion stimuli was abolished 
by silencing of IRE1α. (E) Sec16A dispersion level was quantified as percentage of Sec16A (+) area 
versus total cell area. Results of multiple experiments (mean ±SEM, n ³ 5, each comprising analyses 
of 5–10 cells ***p < 0.001) were summarized. Scale bar: 10 μm. See Table 1-2 for sample size, 
replication and statistical information.
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Figure 20. The graphical summary of Sec16A-facilated conventional and unconventional 
secretion of CFTR. Sec16A is stably associated with the ER exit sites (ERES) and acts as the 
scaffold for both COPII-mediated conventional secretion of CFTR and COPII-independent 
unconventional secretion of CFTR. Sec16A does not dissociate from ERES during the entire process 
in both of the mechanisms. (A) Under normal conditions, Sec16A localizes at the perinuclear ERES
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and mediate the assembly and budding of the COPII-coated vesicles, which contains the wild-type 
CFTR but not ΔF508-CFTR. Wild-type CFTR exports from ER to Golgi and then passes through the 
Trans-Golgi-network (TGN), lastly transports to the cell surface. The ΔF508-CFTR which has 
folding defects would be completely degraded by ER associated degradation pathway (ERAD) and 
failed to reach the cell surface. (B) Once the ER-to-Golgi blockade or GRASP55 overexpression 
induced to the cell, Sec16A relocalizes from perinuclear ERES to peripheral ERES, where is 
adjacent to the cell surface. During this period, phosphorylated GRASP55 relocalizes from Golgi to 
ER and associates with Sec16A at ERES nearby the cell periphery. Core-glycosylated ΔF508-CFTR 
could be brought to newly established ERES and escapes from ER, and unconventionally secretes to 
the cell surface without passing through the Golgi complex. 
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Table 1. The sample size estimation and replication information, by figure
Figure 
number
n
Exact value Paragraph
1B
WT-CFTR(4),Sec16A-siRNA treated WT-CFTR (4);Arf1-
Q71L treated WT-CFTR(4), Arf1-Q71L and Sec16A-siRNA 
treated WT-CFTR(4)
Figure 1 
legend
1D
ΔF508-CFTR (5), Sec16A-siRNA treated ΔF508-CFTR (5); 
Arf1-Q71L treated ΔF508-CFTR (5), Arf1-Q71L and Sec16A-
siRNA treated ΔF508-CFTR (5)
Figure 1 
legend
2C
ΔF508-CFTR expressed control (7), Arf1-Q71L treated(7); 
Sec16A-siRNA and Arf1-Q71L treated (7), Sec16B-siRNA and 
Arf1-Q71L treated (3); Sec23A-siRNA and Arf1-Q71L treated 
(4), Sec23B-siRNA and Arf1-Q71L treated (4); Sec24A-siRNA 
and Arf1-Q71L treated (4),Sec24B-siRNA and Arf1-Q71L 
treated (3), Sec24C-siRNA and Arf1-Q71L treated(3), Sec24D-
siRNA and Arf1-Q71L treated (3); Sec13-siRNA and Arf1-
Q71L treated (3); Sec31A-siRNA and Arf1-Q71L treated (3), 
Sec31B-siRNA and Arf1-Q71L treated (3)
Figure 2 
legend
2E
ΔF508-CFTR expressed control (5), Arf1-Q71L treated(5); 
Sec16A and Sec16B-siRNAs treated (3); Sec23A and Sec23B-
siRNAs and Arf1-Q71L treated (5); Sec24A, Sec24B, Sec24C 
and Sec24D-siRNAs and Arf1-Q71L treated (5); Sec31A and 
Sec31B-siRNAs and Arf1-Q71L treated(5)
Figure 2 
legend
3A Scrambled siRNA treated (3) and Sec16A-siRNA treated (3)
Figure 3 
legend
3B Scrambled siRNA treated (3) and Sec31A-siRNA treated (3)
Figure 3 
legend
3C
Scrambled siRNA treated (3), Sec16A-siRNA (3), Sec16B-
siRNA (3),Sec23A-siRNA (3),Sec23B-siRNA (3),Sec24A-
siRNA (3),Sec24B-siRNA (3),Sec24C-siRNA (3),Sec24D-
siRNA (3),Sec13-siRNA (3), Sec31A-siRNA (3), Sec31B-
siRNA (3)
Figure 3 
legend
4D
WT-CFTR(3),WT-CFTR 37°C 0min (3), WT-CFTR 37°C
15min (3), WT-CFTR 37°C 30min (3), WT-CFTR 37°C 60min 
(3); Dynasore treated WT-CFTR(3), Dynasore treated WT-
CFTR(3), Dynasore treated WT-CFTR 37°C 0min (3), 
Dynasore treated WT-CFTR 37°C 15min (3), Dynasore treated 
WT-CFTR 37°C 60min (3); Dynamin-K44A treated WT-
CFTR(3), Dynamin-K44A treated WT-CFTR(3), Dynamin-
K44A treated WT-CFTR 37°C 0min (3), Dynamin-K44A 
treated WT-CFTR 37°C 15min (3), Dynamin-K44A treated 
WT-CFTR 37°C 60min (3)
Figure 4  
legend
5A
Myc-Transferrin receptor expressed control (3), dynasore 
treated (3) and dynamin2-K44A treated (3)
Figure 5 
legend
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5B
WT-CFTR expressed control (6),dynasore treated (6), Arf1-
Q71L treated (6), dynasore and Arf1-Q71L treated (6)
Figure 5 
legend
5C
ΔF508-CFTR expressed control (6), dynasore treated (6), Arf1-
Q71L treated (6), dynasore and Arf1-Q71L treated (6)
Figure 5 
legend
5D
ΔF508-CFTR expressed control (4), dynamin2-K44A treated 
(4), Arf1-Q71L treated (4),  dynamin2-K44A and Arf1-Q71L 
treated (4)
Figure 5 
legend
6E
WT-CFTR expressed control (25), ΔF508-CFTR (25), Sar1-
T39N treated ΔF508-CFTR (30), Sec16A-siRNA and Sar1-
T39N treated ΔF508-CFTR (30)
Figure 6 
legend
7B
ΔF508-CFTR expressed control (3); Myc-GRASP55, 
GRASP55-Myc, GRASP55 treated (3); Sec16A-siRNA and 
Myc-GRASP55, GRASP55-Myc, GRASP55 treated (3)
Figure 7 
legend
8B Control(3), Arf1-Q71L treated (3)
Figure 8 
legend
9E
perinuclear (5) and peripheral (5) repectively in Control, 
Thapsigargin treated, Arf1-Q71L treated, Sar1-T39N treated 
conditions
Figure 9 
legend
11D Control (5); Arf1-Q71L treated (5)
Figure 10 
legend
12D
Control (5); GRASP55-Myc(low) (5); GRASP55-Myc (high) 
(5)
Figure 12 
legend
14C Control (7), Arf1-Q71L treated (7)
Figure 14 
legend
14G Control (7), GRASP55-Myc treated (7), Sar1-T39N treated (7)
Figure 14 
legend
15E
Control Sec16A and Sec31A(9); GRASP55 overepxressed 
Sec16A (10) and Sec31A (10); Arf1-Q71L treated Sec16A(10), 
Arf1-Q71L treated Sec16A(10), Sar1-T39N treated Sec31A (5) 
and Sec31A (5),
Figure 15 
legend
17E
Control Se24B (7), Arf1-Q71L treated Sec24B; Control Se24D 
(10), Arf1-Q71L treated Sec24D(10);
Figure 17 
legend
18B
ΔF508-CFTR expressed control (3);IRE1α-siRNA treated (3); 
Arf1-Q71L treated (3); IRE1α-siRNA,Arf1-Q71L treated (3); 
Sec16A overepxressed and IRE1α-siRNA,Arf1-Q71L treated
Figure 18 
legend
18D
ΔF508-CFTR expressed control (3);IRE1α-siRNA treated (3); 
GRASP55-Myc treated (3); IRE1α-siRNA,GRASP55-Myc 
treated (3); Sec16A overepxressed and IRE1α-
siRNA,GRASP55-Myc treated (3)
Figure 18 
legend
19E
Control (5), IRE1α-siRNA (5); Arf1-Q71L treated (9), Arf1-
Q71L and IRE1α-siRNA treated (8)
Figure 19 
legend
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Table 2. The statistical information reporting, by figure
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p< 0.0001; ΔF508-
CFTR+Arf1-Q71L vs 
ΔF508-CFTR+ Arf1-
Q71L+Sec23A+B-siRNA 
n.s. ; ΔF508-CFTR+Arf1-
Q71L vs ΔF508-
CFTR+Arf1-
Q71L+Sec24A+B+C+D-
siRNA n.s. ; ΔF508-
CFTR+Arf1-Q71L vs 
ΔF508-CFTR+Arf1-
Q71L+Sec31A+B-siRNA 
n.s.
D
un
ne
tt
's
 M
u
lt
ip
le
 C
o
m
p
ar
is
on
 T
es
t
F
ig
u
re
 2
le
g
en
d
3A
P
ai
re
d
t-
te
st
3
S
cr
am
bl
e
d
 s
iR
N
A
 
tr
ea
te
d
Protein expression of 
Sec16A: Control vs
Sec16A-siRNA treated 
p=0.0055
F
ig
ur
e 
3 
le
ge
nd
3B 3
S
cr
am
b
le
d 
si
R
N
A
 
tr
ea
te
d
Protein expression of 
Sec31A: Control vs 
Sec31A-siRNA treated 
p=0.0003
- 45 -
3C
error 
bars 
are 
mean 
± 
SEM
O
n
e-
w
ay
 A
N
O
V
A
3
S
cr
am
bl
ed
 s
iR
N
A
 t
re
at
ed
mRNA expression ANOVA 
summary: p< 0.0001;                                    
Dunnett's Multiple 
Comparison Test: control vs 
Sec16A-siRNA treated 
p< 0.0001; control vs 
Sec16B-siRNA p< 0.0001; 
control vs Sec23A-siRNA  
p< 0.0001; control vs 
Sec23B-siRNA 
p<0.0001;control vs 
Sec24A-siRNA p< 0.0001; 
control vs Sec24B-siRNA  
p< 0.0001; control vs 
Sec24C-siRNA p< 0.0001; 
control vs Sec24D-siRNA 
p< 0.0001; control vs 
Sec13-siRNA p< 0.0001; 
control vs Sec31A-siRNA  
p< 0.0001; control vs 
Sec31B-siRNA p< 0.0001
D
un
n
et
t's
 M
ul
ti
p
le
 C
om
p
ar
is
on
 T
es
t
F
ig
ur
e 
3 
le
ge
n
d
3D 3
S
cr
am
b
le
d
 
si
R
N
A
 t
re
at
ed
mRNA expression ANOVA 
summary: p< 0.0001;                                    
Dunnett's Multiple 
Comparison Test: control vs 
Sec16A-siRNA treated p< 
0.0001; control vs Sec16B-
siRNA p< 0.0001;
3E 3
S
cr
am
b
le
d
 
si
R
N
A
 t
re
at
ed
mRNA expression ANOVA 
summary: p< 0.0001;                                    
Dunnett's Multiple 
Comparison Test: control vs 
Sec23A-siRNA treated
p< 0.0001; control vs 
Sec13B-siRNA p< 0.0001.
3F 3
S
cr
am
bl
ed
 s
iR
N
A
 t
re
at
ed
mRNA expression ANOVA 
summary: p< 0.0001;                                    
Dunnett's Multiple 
Comparison Test: control vs 
Sec24A-siRNA treated p< 
0.0001; control vs Sec24B-
siRNA p< 0.0001; control 
vs Sec24C-siRNA 
p<0.0001; control vs 
Sec24D-siRNA p< 0.0001.
- 46 -
3G
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
3
S
cr
am
b
le
d
 s
iR
N
A
 
tr
ea
te
d
mRNA expression ANOVA 
summary: p< 0.0001;                                    
Dunnett's Multiple 
Comparison Test: control vs 
Sec31A-siRNA treated  
p< 0.0001; control vs 
Sec31B-siRNA p< 0.0001.
D
un
ne
tt
's
 M
ul
ti
pl
e 
C
om
pa
ri
so
n 
T
es
t
F
ig
u
re
 3
 l
eg
en
d
4D 3
WT-
CFTR
Internalized CFTR(0min) 
ANOVA summary: 
p=0.1116; 
Dunnett's Multiple 
Comparison Test:
0 min CFTR vs 
CFTR+Dynasore n.s.; 0 min 
CFTR vs CFTR+Dynamin-
K44A n.s.;
Internalized CFTR(15min) 
ANOVA summary: 
p=0.0001; 
Dunnett's Multiple 
Comparison Test:
15min CFTR vs 
CFTR+Dynasore p< 0.001; 
15min CFTR vs 
CFTR+Dynamin-K44A 
p< 0.001;
Internalized CFTR(30min) 
ANOVA summary: p< 0.01; 
Dunnett's Multiple 
Comparison Test: 30min 
CFTR vs CFTR+Dynasore 
p< 0.01; 30min CFTR vs 
CFTR+Dynamin-K44A  
p< 0.05;
Internalized CFTR(60min) 
ANOVA summary: 
p< 0.0001;
Dunnett's Multiple 
Comparison Test: 60min 
CFTR vs CFTR+Dynasore 
p< 0.0001; 60min CFTR vs 
CFTR+Dynamin-K44A  
p< 0.0001
F
ig
ur
e 
4 
le
ge
nd
- 47 -
5A
error 
bars 
are 
mean 
± 
SEM
O
n
e-
w
ay
 A
N
O
V
A
3
T
ra
n
sf
er
ri
n 
re
ce
p
to
r 
o
nl
y Surface expression of TFRC 
Rc ANOVA summary: 
p=0.0003;                              
Dunnett's Multiple 
Comparison Test: 
control vs dyasore treated 
p<0.01; 
control vs dynamin2-K44A 
treated p<0.001
D
u
n
ne
tt
's
 M
u
lt
ip
le
 
C
o
m
pa
ri
so
n 
T
es
t
F
ig
u
re
 5
 l
eg
en
d
5B
P
ai
re
d 
t-
te
st
6
u
nt
re
at
ed
 
W
T
-C
F
T
R
 
(b
an
d 
C
) Surface expression of CFTR 
band C: control vs dynasore 
treated p=0.0017
Arf1-
Q71L 
treated 
WT-
CFTR 
(band 
B)
Surface expression of CFTR 
band B: control vs dynasore 
treated p=0.7561
5C
O
ne
-w
ay
 A
N
O
V
A 6
Arf1-
Q71L 
treated 
ΔF508-
CFTR
Surface expression of 
ΔF508-CFTR ANOVA 
summary: not significant
D
u
nn
et
t's
 M
u
lt
ip
le
 
C
om
p
ar
is
on
 T
es
t
5D 4
Arf1-
Q71L 
treated 
ΔF508-
CFTR
Surface expression of 
ΔF508-CFTR ANOVA 
summary: not significant
6E
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
WT-
CFTR
Surface CFTR fluorescence 
intensity ANOVA summary: 
p< 0.0001; 
Dunnett's Multiple 
Comparison Test: 
WT-CFTR vs ΔF508-CFTR 
p< 0.001; 
WT-CFTR vs Sar1-T39N 
treated ΔF508-CFTR 
p< 0.05; 
WT-CFTR vs Sar1-T39N 
and Sec16A siRNA treated 
ΔF508-CFTR 
p< 0.01. D
un
ne
tt
's
 M
ul
ti
pl
e 
C
om
pa
ri
so
n 
T
es
t
F
ig
ur
e 
6
le
ge
nd
- 48 -
7B
error 
bars 
are 
mean 
± 
SEM
P
ai
re
d 
t-
te
st
3
Myc-
GRASP
55 
treated 
ΔF508-
CFTR
Surface expression Control 
vs Sec16A depleted: 
p=0.0035
F
ig
ur
e 
7 
le
ge
nd
GRASP
55-Myc 
treated 
ΔF 508-
CFTR
Surface expression: Control 
vs Sec16A depleted  
p=0.0019
GRASP
55 
treated 
ΔF508-
CFTR
Surface expression: 
Control vs Sec16A depleted  
p=0.0088
8B 3
Sec16A 
and 
GRASP
55 
coexpre
ssed
IP fold change: 
control vs Arf1-Q71L 
treated p=0.0074 F
ig
u
re
 8
 
le
g
en
d
9E
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
5
P
er
in
uc
le
ar
 o
f 
u
nt
re
at
ed
 c
el
l Perinuclear 
colocalization(%) ANOVA 
summary: p< 0.0001;            
Dunnett's Multiple 
Comparison Test: 
control vs thapsigargin 
treated p< 0.001; 
control vs Arf1-Q71L 
treated p< 0.0001; 
control vs Sar1-T39N 
treated p< 0.0001
D
un
ne
tt
's
 M
ul
ti
pl
e 
C
om
pa
ri
so
n 
T
es
t
F
ig
u
re
 9
 l
eg
en
d
P
er
ph
er
al
 o
f 
un
tr
ea
te
d 
ce
ll
Peripheral colocalization(%) 
ANOVA summary: 
p< 0.0001;             
Dunnett's Multiple 
Comparison Test: 
control vs thapsigargin 
treated p< 0.05; 
control vs Arf1-Q71L 
treated p< 0.001; 
control vs Sar1-T39N treated 
p< 0.0001
- 49 -
11
D
error 
bars 
are 
mean 
± 
SEM
P
ai
re
d
 t
-
te
st 5
U
n
tr
ea
te
d
 
ce
ll
Sec16A(+)/Total cell 
area(%):
control vs Arf1-Q71L 
treated cell p< 0.0001 F
ig
u
re
 1
1 
le
g
en
d
12
D
O
n
e-
w
ay
 A
N
O
V
A
5
U
n
tr
ea
te
d
 c
el
l
Sec16A(+)/Total cell 
area(%) ANOVA summary: 
p< 0.0001;             
Dunnett's Multiple 
Comparison Test control vs 
GRASP55-Myc(low) n.s.; 
control vs GRASP55-
Myc(high) p< 0.0001
D
un
n
et
t's
 M
ul
ti
p
le
 
C
om
p
ar
is
o
n 
T
es
t
F
ig
ur
e 
1
2 
le
g
en
d
14
C
P
ai
re
d
 t
-t
es
t
6
U
nt
re
at
ed
 c
el
l
Sec16A colocalize with ER-
YFP/Total Sec16A(MCC): 
control vs Arf1-Q71L: 
p< 0.0001
D
un
ne
tt
's
 M
u
lt
ip
le
 
C
om
pa
ri
so
n 
T
es
t
F
ig
ur
e 
14
 l
eg
en
d
ER-YFP colocalize with 
Sec16A/Total ER-
YFP(MCC): control vs 
Arf1-Q71L: 
p< 0.0001
14
G
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
6
U
nt
re
at
ed
 c
el
l
Sec16A colocalize with ER-
Calnexin/Total 
Sec16A(MCC) ANOVA 
summary: p< 0.0001;
Dunnett's Multiple 
Comparison Test
control vs GRASP55-Myc: 
p< 0.0001; 
control vs Sar1-T39N: 
p< 0.0001;
D
un
ne
tt
's
 M
u
lt
ip
le
 C
om
pa
ri
so
n 
T
es
t
F
ig
u
re
 1
4 
le
ge
nd
ER-Calnexin colocalize with 
Sec16A /Total ER-Calnexin 
(MCC) ANOVA summary: 
p< 0.0001
Dunnett's Multiple 
Comparison Test
control vs GRASP55-Myc: 
p< 0.0001; 
control vs Sar1-T39N: 
p< 0.0001;
- 50 -
15
E
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
5~9
U
nt
re
at
ed
 c
el
l
Sec16A(+)/Total cell 
area(%) ANOVA summary: 
p< 0.0001;                             
Dunnett's Multiple 
Comparison Test: control vs 
GRASP55 treated p< 0.001;  
control vs Sar1-T39N 
treated p< 0.001                                                         
Sec31A(+)/Total cell 
area(%) ANOVA summary: 
p value n.s.
F
ig
u
re
 1
5 
le
g
en
d
17
E
P
ai
re
d
 t
-t
es
t
5
U
nt
re
at
ed
 c
el
l
Sec24B(+)/Total cell 
area(%): control vs Arf1-
Q71L: n.s.
Sec24D(+)/Total cell 
area(%): control vs Arf1-
Q71L: n.s. F
ig
u
re
 1
7 
le
ge
n
d
18
B
O
ne
-w
ay
 A
N
O
V
A
3
IR
E
1 
de
pl
et
ed
, A
rf
1
-Q
71
L
 t
re
at
ed
 
Δ
F
50
8
-C
F
T
R
Surface expression of 
ΔF508-CFTR ANOVA 
summary: p< 0.0001;                
Dunnett's Multiple 
Comparison Test:      
ΔF508-CFTR+Arf1 vs  
ΔF508-CFTR+ Arf1+IRE1-
siRNA treated p<0.001; 
ΔF508-CFTR+Arf1+IRE1-
siRNA  vs ΔF508-
CFTR+Arf1+IRE1-
siRNA+Sec16A-Myc 
p<0.001
F
ig
u
re
 1
8 
le
ge
n
d
- 51 -
18
D
error 
bars 
are 
mean 
± 
SEM
O
ne
-w
ay
 A
N
O
V
A
3
IR
E
1
 d
ep
le
te
d,
 G
R
A
S
P
55
 t
re
at
ed
 
Δ
F
5
08
-C
F
T
R
Surface expression of 
ΔF508-CFTR ANOVA 
summary: p< 0.0001;                
Dunnett's Multiple 
Comparison Test:      
ΔF508-CFTR+GRASP55 vs 
ΔF508-CFTR+ GRASP55+ 
IRE1-siRNA treated 
p<0.001; ΔF508-CFTR 
+GRASP55+IRE1-siRNA  
vs ΔF508-
CFTR+GRASP55+IRE1-
siRNA+Sec16A-Myc 
p<0.001
19
E
5~8
U
nt
re
at
ed
 c
el
l
Sec16A(+)/Total cell area 
ANOVA summary: 
p< 0.0001;                              
Dunnett's Multiple 
Comparison Test: 
control vs Arf1Q71L treated 
p< 0.001; control vs
Arf1Q71L+IRE1-siRNA 
treated n.s.
F
ig
ur
e 
19
 l
eg
en
d
- 52 -
IV. DISCUSSION
Most of the secretory proteins exit the ER through cargo sorting and COPII-coated 
vesicles form at the specific locations on the ER membrane called ER exit sites (EREs) 22,47, 
consequently target to various intracellular destinations including Golgi complex, 
endosomes, lysosomes and the plasma membrane. In recent years, the process named 
unconventional secretory pathway is revealed to facilitate proteins secrete from ER and 
directly sort to the cell surface without entering Golgi-mediated conventional secretory 
pathway.10,19,48 In current study, we demonstrate the function of ER exit sites in initiation of 
unconventional secretion and the scaffolding role of Sec16A that regulates the formation of 
GRASP-mediated tethering of cargo proteins through interacting with GRASPs. This 
interaction could be promoted by ER-to-Golgi blockade which induces the relocalization of 
GRASPs from Golgi to ERES. Additionally, upregulation of GRASPs alone attributes to 
localization change of GRASPs accompanying with Sec16A, which provides more 
opportunity for their interaction. A loss of Sec16A abolishes both COPII-dependent 
secretion of wild-type CFTR and COPII-independent unconventional secretion of mutant 
ΔF508-CFTR. Interestingly, depletion of IRE1α also contributes to impairment of adaptive 
Sec16A neo-synthesis in response to ER-to-Golgi blockade or ER stress and disruption of 
unconventional ΔF508-CFTR secretion at ERES.
Sec16A has been identified as a characterized modulator of ERES biogenesis rather than 
a coat component,26,28 making an indispensable contribution to the organization of ERES29
and COPII-mediated ER export.38,49 Sec16 is a large hydrophilic protein tightly associating
with ERES and its localization at ERES is independent of downstream COPII components 
which cycle on and off the membrane during the ER-to-Golgi transport.29 RNAi-mediated 
knockdown of Sec16 was previously reported to disrupt ERES and ER export of 
glycoprotein.31,38 Additionally, it was identified that TFG-1 depletion leads to impairment of 
assembling of scaffolding protein Sec16 with COPII complexes giving rise to abolishment 
of ER export.50 When the anchoring of Sec16A at the ERES was weakened by loss-of-
function of Lrrk2 (Leucine-rich repeat kinase2, Parkinson’s disease related gene), ER-to-
Golgi export was impaired because of dysfunction of ERES.51 In consideration of these 
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findings, we intuitively assume that Sec16A acts as a functional regulation factor for 
assembling of GRASP and misfolded proteins at the early stages of unconventional 
secretion. 
1. Sec16A functions as a scaffolding protein for unconventional secretion 
independent of COPII-related manner.
The inhibition of conventional ER-to-Golgi secretory pathway could be induced by 
expression of dominant-negative form of Sar1 which is the GTPase catalysing COPII 
assembly or expression of dominant-negative form of Arf1 which is the GTPase catalyzing
assembly of COPI components.40,52 Extraordinarily, trafficking of CFTR could not be 
completely abolished but the ER core-glycosylated form could transport to the cell surface 
bypassing the Golgi instead.10,41 Interestingly, in our results, both complex-glycosylated and 
core-glycosylated form of CFTR could not reach the cell surface following the depletion of 
Sec16A (Figure 1, 2, 6). Unlike Sec16A, COPII coat components are not involved in 
formation of GRASP-mediated unconventional secretory vesicles (Figure 2). In addition to 
this, the stimuli activating unconventional secretion resulted in Sec16A relocalized to the 
ERES nearby the cell periphery but Sec31A relocalized to the ERES adjacent to the nucleus
MTOC resulting in dysfunction of ER-to-Golgi anterograde transport (Figure 15, 16). These 
results suggest that Sec16A takes participates in GRASP-mediated unconventional secretion 
no matter that COPII-mediated ER export was abolished. Taken together, the scaffolding 
role of Sec16A in the unconventional secretion route is independent of COPII machinery. 
2. Sec16A interacts and synchronizes its redistribution with GRASP55 during 
unconventional secretion.
It is noticeable that Sec16 stabilize COPII assembly by interacting with cargo-Sec23-
Sec24 to prevent premature disassembly of COPII.27,53,54 Our previous study indicated that 
blockade of ER-to-Golgi route enabled the interaction between GRASP and core-
glycosylated CFTR.10 When it comes to the present study, ER-to-Golgi blockade also 
promoted GRASP55 to associate with Sec16A (Figure 8), suggesting that Sec16A may 
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recruit the Golgi localized GRASP55 onto ERES firstly and form complexes with 
GRASP55 containing the ΔF508-CFTR cargos under the conditions of ER-to-Golgi 
blockade. 
GRASP65 and GRASP55 are Golgi matrix proteins attach peripherally to the cytoplasmic 
surface of Golgi membrane of the cis- and medial-trans cisternae, respectively.14 Therefore, 
in the beginning of our study, how these Golgi-localized proteins encounter and survive the 
ER-localized misfolded proteins and finally facilitate them transport to the plasma 
membrane was the problem we focus on. Fortunately, we found the GRASPs dissociate
from Golgi membrane and redistribute toward the cell periphery. It has been revealed in our 
recent report that the ER relocalization of GRASP55 provides a sufficient condition for 
unconventional secretion of CFTR.46 It is worth pointing out that the major subcellular 
localization of Sec16A directs to the cell periphery altogether with GRASP55 when ER-to-
Golgi transport was block (Figure 11C) which enabled the surface expression of ΔF508-
CFTR (Figure 11B). We further confirmed these observations in the GRASP-overepxressed 
cells (Figure 12), where unconventional secretion could also be facilitated. In consistent 
with previous report,10overexpression of GRASP55 resulted in surface rescue of ΔF508-
CFTR but the rescue effects was diminished by Sec16A depletion (Figure 7) indicating that
GRASP-mediated unconventional secretion depends on the assistance of Sec16A. 
Surprisingly, low expression of exogenous GRASP could not induce the surface expression 
of ΔF508-CFTR (Figure 13A), moreover, low expression of GRASP55 was ineffective on 
Sec16A redistribution comparing to high expression of GRASP55 (Figure 12B, C). High 
expression of GRASP55 led to redistribution of Sec16A to the periphery of the cells and 
surface expression of ΔF508-CFTR (Figure 12C, D and Figure 13B), providing an evidence 
for illustrating the significance of relocalization of both Sec16A and GRASP55 in 
unconventional secretion. In a word, Sec16A regulating the initiation of unconventional 
secretion cooperates with GRASPs.
3. IRE1α-mediated UPR acts as upstream modulator for Sec16A in the 
unconventional secretion.
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Another noticeable finding of our study is that the de novo generation of the scaffolding 
protein Sec16A in response to ER stress or upregulation of GRASP is regulated by IRE1α-
mediated UPR. ER relieve the ER stress resulting from accumulation of unfolded proteins 
and by triggering UPR related signaling pathway to maintain homeostasis in the ER 
lumen,.55 Generally, UPR reduces the protein load in ER by decreasing the gene 
transcription and translation of secretory proteins and rebalances the protein folding 
homeostasis by removing misfolded proteins into ERAD.56 In our previous study, ER stress 
activated the cell surface targeting secretion of misfolded proteins via the unconventional 
route to relieve the ER burden,10 which could also be considered as a result of UPR. IRE1α
is one of ER stress sensors containing three branches of signaling activating the UPR.32 The 
chronic increase of cargo load in ER triggered UPR and sequentially new ERES generated 
in order to enhance the secretory flux. This chronic adaption of ERES generation was 
identified to be dependent on IRE1α-controlled UPR.31 Moreover, basal activity of IRE1α is 
also critically involved in GRASP-mediated rescue of ΔF508-CFTR.10 Our current findings 
now clearly demonstrate the IRE1α -mediated UPR is the upstream signaling that regulates 
newly generation and anchoring of Sec16A at ERES to make preparation for GRASP-
mediated unconventional secretion. Depletion of IRE1α consequently inhibited the surface 
expression of ΔF508-CFTR, fortunately, ΔF508-CFTR simply rescued by supplementation
of Sec16A (Figure 18). In combination with the previous opinion that cargo load triggering 
UPR results in a strong induction of Sec16A and generation of new ERES,31 UPR triggered 
by misfolded ΔF508-CFTR failed to transmit this signal through IRE1α-signaling due to
IRE1α depletion. As a result, additional induction of Sec16A was abandoned and pre-
existing Sec16A was insufficient to assemble ΔF508-CFTR at the ERES. These results 
altogether suggest that Sec16A provide more spatial opportunities for ΔF508-CFTR exit 
from ER during unconventional secretion and the amount of Sec16A is upregulated by 
IRE1α-controled UPR. 
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V. CONCLUSION
The misfolded mutant ΔF508-CFTR could be rescued from ER associated degradation 
(ERAD) and this process is dependent on GRASP mediated unconventional secretion. The 
current investigation shows that Sec16A, the key regulator of ER exit sites organization, is 
also responsible for both the conventional and unconventional secretion of CFTR. Sec16A
cooperates with GRASP to assemble the vesicles containing ΔF508-CFTR when the ER-to-
Golgi transport was blocked. The role of Sec16A that facilitates the unconventional 
secretion is due to its plus-end-toward relocalization in response to ER-to-Golgi blockade or 
GRASP55-overexpression. Subsequently, Sec16A provides the ΔF508-CFTR with a 
convenient platform near the cell periphery to escape from ER and directly transport to the 
cell surface. Moreover, the regulatory function of Sec16A in the unconventional secretion is 
modulated by IRE1α-mediated UPR.
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Abstract (in Korean)
GRASP을 통한 비전형적 단백이동경로에서
ER exit sites의 역할
<지도교수 이 민 구>
연세대학교 대학원 의과학과
박 학
낭포성 섬유증 유발 세포막 단백질(Cystic Fibrosis Transmembrane Conductance 
Regulator, CFTR)은 생체 내 기도, 장, 췌장 및 외분비선 등 장기의 상피세포
선단 표면에서 염소이온 및 중탄산이온을 비롯한 음이온의 수송을 조절하는
중요한 단백질이다. CFTR 의 508번째 페닐알라닌이 소실되는 ΔF508-
CFTR 돌연변이는 낭포성 섬유증(Cystic Fibrosis, CF)을 유발하는 가장 흔한
유전변이이다. 일반적인 CFTR 단백의 경우 소포체(Endoplasmic Reticulum, ER)-
골지체(Golgi apparatus)간 수송을 거쳐 세포막에 도달하게 되지만 ΔF508-CFTR 
돌연변이 단백의 경우 접힘 장애를 가지게 되어 소포체 품질검사를 통과하지
못하고 소포관련 분해기전(ER associated degradation, ERAD)을 통해 분해되는
것으로 알려져 있다. 
소포체-골지체간의 단백질 수송을 억제하거나 소포체 스트레스를 유발할
경우 ΔF508-CFTR 돌연변이 단백이 골지체를 우회하는 비전형적
이동경로(Unconventional secretory pathway)를 통해 세포막으로 수송되어
이온수송능력이 회복되고, 이는 GRASP (Golgi reassembly stacking protein) 에
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의존적이라는 것이 선행 연구에서 보고된 바 있다. 또한 소포체 스트레스를
유발하지 않더라도 GRASP 의 과발현에 의해서도 비전형적 이동경로를 통한
ΔF508-CFTR 돌연변이 단백의 수송과 기능이 회복되는 것이 세포 및
생쥐모델을 통해서 확인되었다. 그러나 현재까지 접힘 장애가 있는 ΔF508-
CFTR 이 어떻게 소포체에서 떠나 비전형적 이동경로를 통하여 세포막에
도달하는 지에 대한 정확한 기전은 밝혀진 바 없다. 따라서 본 연구에서는
이러한 기전을 밝히는 것을 주요 연구 목표로 하였다.
본 연구를 통해 소포체 출구부위(ER exit sites, ERES)에 존재 하며 소포체
출구부위의 형성에 핵심적인 역할을 하는 Sec16A 라는 단백이 비전형적
단백수송의 시작단계에서도 중요한 역할을 수행함을 밝혔다. Sec16A 의 기능을
억제한 경우 CFTR 의 전형적 수송 및 비전형적 수송이 모두 봉쇄됨을
통해서 Sec16A 가 CFTR 의 전형적 수송뿐만 아니라 비전형적 수송에도
관련이 있음을 확인하였다. 특히 ΔF508-CFTR 의 비전형적 수송을 일으키는
조건에서 Sec16A 는 GRASP55와 결합하며 세포내 분포도 GRASP55와 같이
세포핵 주변 으로부터 세포막 근처로 이동한다는 것을 공초점 형광현미경을
이용한 이미지 관찰을 통하여 알 수 있었다. 이는 Sec16가 비전형적
단백수송경로에서 GRASP55와 ΔF508-CFTR 를 세포막 가까운 부위에서 새로
생성된 소포체 출구부위에서의 결합을 돕는 스캐폴드(scaffold)로서의 역할을
수행함을 시사한다. 또한, IRE1α 에 의해 매개되는 비접힘 단백질
반응(Unfolded protein response, UPR) 신호가 이러한 Sec16A 의 작용에 관여하는
상위조절 인자임을 확인하였다.
이상의 결과를 통하여 비전형적인 단백수송경로를 통한 ΔF508-CFTR 의
세포막 발현은 Sec16A 에 의존적이라는 것을 밝혔으며 이는 낭포성 섬유증, 
췌장염을 비롯한 단백 접힘 이상으로부터 기인하는 여러 질환들의 치료제
개발에 있어서 새로운 대안을 제시할 것으로 기대된다.
핵심되는 말: 비전형적 단백수송, 낭포성 섬유증, GRASP, Sec16A, 소포체
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